AstraZeneca Pharma India Limited announced audited earnings results for the fourth quarter and full year ended March 31, 2018. For the quarter, the company reported revenue from operations of INR 1,507.266 million compared to INR 1,168.814 million a year ago. Total revenue was INR 1,530.648 million compared to INR 1,178.733 million a year ago. Profit before exceptional and extraordinary items and tax was INR 140.568 million compared to loss of INR 19.887 million a year ago. Profit before tax was INR 140.568 million compared to loss of INR 19.887 million a year ago. Profit for the period was INR 32.214 million compared to loss of INR 95.596 million a year ago. Basic and diluted earnings per share were INR 1.29 compared to loss of INR 3.82 a year ago. For the year, the company reported revenue from operations of INR 5,719.892 million compared to INR 5,486.551 million a year ago. Total revenue was INR 5,842.368 million compared to INR 5,630.444 million a year ago. Profit before exceptional and extraordinary items and tax was INR 438.001 million compared to INR 355.042 million a year ago. Profit before tax was INR 438.001 million compared to INR 355.042 million a year ago. Profit for the period was INR 259.148 million compared to INR 200.548 million a year ago. Basic and diluted earnings per share were INR 10.37 compared to INR 8.02 a year ago.